The global Hypopituitarism Diagnostics Market is expected to garner a market value of US$ 250 Million in 2023 and is expected to accumulate a market value of US$ 447.41 Million by registering a CAGR of 6% in the forecast period 2023-2033. The market for Hypopituitarism Diagnostics registered a CAGR of 4% in the historical period …
Category Archives: Healthcare Trends
Takotsubo Syndrome Therapeutics Market to reach US$ 2.85 Billion by 2033; growing at a CAGR of 6.1%: FMI Report
The global takotsubo syndrome therapeutics market is predicted to exceed an impressive valuation of US$ 2.85 Billion in 2033, with a compound annual growth rate (CAGR) of 6.1% estimated from 2023 to 2033. In both industrialized and developing economies, cardiovascular diseases are the leading cause of death. The rising prevalence of cardiovascular problems such as …
Rising Focus of Government Organizations to Propel the Growth in the Market for Congenital Hyperinsulinism Treatment at 6% CAGR: FMI Study
The global Congenital Hyperinsulinism Treatment Market is expected to garner a market value of US$ 100 Million in 2023 and is expected to accumulate a market value of US$ 179.08 Million by registering a CAGR of6% in the forecast period 2023-2033. The market for Congenital Hyperinsulinism registered a CAGR of 4% in the historical period …
Andersen Tawil Syndrome Treatment Market to reach US$ 4.2 Billion by 2033; Type-1 Treatment to comprise 59% of all Procedures: FMI Report
As per a recently published study by Future Market Insights, the global Andersen Tawil syndrome treatment market is expected to surpass an impressive valuation of US$ 1.9 Billion in 2023 and is projected to reach US$ 4.2 Billion by 2033, with a CAGR of 8.26%. Rising government assistance, provision of incentives to pharmaceutical companies, increasing …
PCSK9 Inhibitors Sales to expand at a 15.8% CAGR from 2023 to 2033, Repatha-based Inhibitors to be Most Widely Used: FMI Report
A recently published study by FMI expects the global PCSK9 inhibitors market to augment at a 15.8% CAGR from 2022 to 2032. By the end of the said assessment period, a valuation of US$ 13 Billion is expected for the market. Monoclonal antibodies are a kind of biologic medicine that inhibits PCSK9. PCSK9 inhibitors bind …
Oncolytic Virus Cancer Therapy Market Value to reach US$ 250 Million by 2033; growing at a whopping 27% CAGR: FMI Report
According to a recent study published by Future Market Insights, the market for oncolytic virus cancer therapy is forecast to reach a valuation of US$ 22.86 Million by 2023-end, and will eventually reach US$ 250 Million by 2033, growing at an astronomical CAGR of 27%. Governments in various emerging economies have captured steps to raise …
Mobile Clinics Market to Surpass US$ 8.1 Billion Revenue by the year 2032 Attributing to Rising Healthcare Expenses Globally
The global mobile clinics market is expected to showcase a positive growth outlook of the global mobile clinics market by exhibiting a total CAGR of around 11.3% from 2022 to 2032. The global market is expected to enjoy a valuation of US$ 2.8 Bn by the end of the year 2022 and surpass a valuation …
Freeze Drying Market Growth Accelerating with Increasing Applications in Biopharmaceutical and Food Industries: Future Market Insights
[250 Pages Report] According to Future Market Insights’ most recent industry report, the global freeze drying market was valued at approximately US$ 1.0 Bn in 2021 and is expected to rise at a CAGR close to 8.5% over the forecast period, with an anticipated worth of around US$ 2.5 Bn in 2032. Freeze drying often …
Dentures Market Growth Accelerating with Increasing Incidence of Periodontal Diseases, and a Growing Elderly Population: Future Market Insights
[250 Pages Report] According to Future Market Insights’ most recent industry report, the global dentures market was valued at approximately US$ 1.6 Bn in 2021 and is expected to rise at a CAGR close to 6.7% over the forecast period, with an anticipated worth of around US$ 3.2 Bn in 2032. For people with partial …
Monoclonal Antibodies Market to touch US$ 648.01 Billion by 2032; applications abound in Oncology: FMI Report
[286 Pages Report] The global demand for monoclonal antibodies is projected to increase at a CAGR of 12% during the forecast period between 2022 and 2032, reaching a total of US$ 647.01 Billion in 2032, according to a report from Future Market Insights (FMI). From 2017 to 2021, sales witnessed significant growth, registering a CAGR …